ERBB2 and dysplasia: We found HER-2/TOPOIIα gene amplification/protein overexpression and chromosome 17 aneusomy (polysomy) in a high proportion of patients with dysplasia (LGD and HGD) or ADC, but in almost none of the patients with BO, suggesting involvement of these factors in cancer development.